[Clinical study on integrative medicine for preventing and treating post-transcatheter arterial chemoembolization]

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 Jun;25(6):534-6.
[Article in Chinese]


Objective: To observe the effects of ginsenosides (GS) and low dose glucocorticoid for preventing and treating the post-transcatheter arterial chemoembolization (TACE) syndrome.

Methods: Adopting randomized, double blinded, controlled method, 80 patients with primary liver cancer were divided into 4 groups, placebo group, dexamethasone (Dex) group, Ginsenosides (GS) group, and Dex combined with GS group to observe the clinical effect of the patients after TACE.

Results: Dex combined with GS could markedly lower the occurrence of nausea, vomiting, fever and pain, and the median time of symptoms persistence, also alleviate the bone marrow inhibition of chemotherapy.

Conclusion: Dex combined with GS could effectively prevent and treat TACE syndrome.

Publication types

  • Clinical Trial
  • English Abstract
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Hepatocellular / drug therapy
  • Chemoembolization, Therapeutic / adverse effects*
  • Dexamethasone / therapeutic use*
  • Double-Blind Method
  • Drug Therapy, Combination
  • Drugs, Chinese Herbal / therapeutic use
  • Female
  • Fever / chemically induced
  • Ginsenosides / therapeutic use*
  • Humans
  • Liver Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Phytotherapy*
  • Syndrome
  • Vomiting / chemically induced


  • Drugs, Chinese Herbal
  • Ginsenosides
  • Dexamethasone